Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer

We report the failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer. A 76-year-old man was admitted to our hospital for evaluation of an elevated serum prostate specific antigen (PSA) level (191.10 ng/ml...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Yoko, Kawashima, Atsunari, Ujike, Takeshi, Nagahara, Akira, Fujita, Kazutoshi, Kiuchi, Hiroshi, Imamura, Ryoichi, Miyagawa, Yasushi, Nonomura, Norio, Uemura, Motohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566291/
https://www.ncbi.nlm.nih.gov/pubmed/32804697
http://dx.doi.org/10.1097/CAD.0000000000000986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566291/
https://www.ncbi.nlm.nih.gov/pubmed/32804697
http://dx.doi.org/10.1097/CAD.0000000000000986

Ejemplares similares